ConductScience.org, home

Paper19954271

Non-adherence to statin therapy: a major challenge for preventive cardiology.

Bates TR and 2 others. Expert Opin Pharmacother, 2009. Cited by 121 papers, by iCite.

Cite this record

ConductScience Library. Non-adherence to statin therapy: a major challenge for preventive cardiology. Papers, record 19954271. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19954271

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Non-adherence to statin therapy: a major challenge for preventive cardiology.
PubMed
Journal
Expert Opin Pharmacother
PubMed
Year
2009
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
121
iCite
Relative citation ratio, by iCite
3.54
iCite
Revised in PubMed
2026-01-28
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bates TRT R
2Connaughton VMV M
3Watts GFG F

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cardiovascular DiseasesMajor topic
Hydroxymethylglutaryl-CoA Reductase InhibitorsMajor topic
HypercholesterolemiaMajor topic
Medication AdherenceMajor topic
Drug MonitoringMajor topic
Health Care Costs
Humans
Treatment Outcome

Source PubMed

Download CSV of topics

Cited by60

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 121 citations.

PMIDTitleJournalYearIn PapersSource
42640402The Complex Interplay Between Dyslipidemic Subjects Living with Type 2 Diabetes and Metabolic Syndrome and Statin Treatment: A Reflection on Adherence and Persistence in the Real World.Diabetes Ther2026https://conductscience.org/library/papers/42640402PubMed
42239507Chinese expert consensus on the choice of initial cholesterol-lowering strategy.Front Pharmacol2026https://conductscience.org/library/papers/42239507PubMed
41869520Biopsychosocial approach in cardiological care: a scoping review of integrated treatments for personalized patient care.Front Cardiovasc Med2026https://conductscience.org/library/papers/41869520PubMed
40560927Statin adherence improves with age and subsequent treatment sequences: A retrospective cohort study using Proportion of Days Covered (PDC).PLoS One2025https://conductscience.org/library/papers/40560927PubMed
40386799Perceptions and Knowledge of Cholesterol and Lipid-Lowering Medications Among Treatment-Naive Individuals: A Cross-Sectional Study.Patient Prefer Adherence2025https://conductscience.org/library/papers/40386799PubMed
40247026Primary care telehealth in a dynamic healthcare environment from digital divide to healthcare outcomes.NPJ Digit Med2025https://conductscience.org/library/papers/40247026PubMed
39174014
Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate-Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE).
Endocrinol Metab (Seoul)2024https://conductscience.org/library/papers/39174014PubMed
39076473Review of Evolocumab for the Reduction of LDL Cholesterol and Secondary Prevention of Atherosclerotic Cardiovascular Disease.Rev Cardiovasc Med2024https://conductscience.org/library/papers/39076473PubMed
37954557Appropriate Use of Primary Statin Preventive Therapy Among Patients with High Atherosclerosis-Related Cardiovascular Disease Risks: Cross-Sectional Study, Northeast Ethiopia.Vasc Health Risk Manag2023https://conductscience.org/library/papers/37954557PubMed
37804438Real-World Insights into Evolocumab Use in Patients with Hyperlipidemia Across Five Countries: Analysis from the ZERBINI Study.Cardiol Ther2023https://conductscience.org/library/papers/37804438PubMed
37361205Relationships between beliefs about statins and non-adherence in inpatients from Northwestern China: a cross-sectional survey.Front Pharmacol2023https://conductscience.org/library/papers/37361205PubMed
37239603Challenges in Improving Adherence to Diet and Drug Treatment in Hypercholesterolemia Patients.Int J Environ Res Public Health2023https://conductscience.org/library/papers/37239603PubMed
37128384Clinical Data Repositories: Primary Sources of Drug-to-Drug Interaction Detection and Risk Assessment.AMIA Annu Symp Proc2022https://conductscience.org/library/papers/37128384PubMed
36853604Assessment of Sex Disparities in Nonacceptance of Statin Therapy and Low-Density Lipoprotein Cholesterol Levels Among Patients at High Cardiovascular Risk.JAMA Netw Open2023https://conductscience.org/library/papers/36853604PubMed
36718804Examining the Impact of Polygenic Risk Information in Primary Care.J Prim Care Community Health2023https://conductscience.org/library/papers/36718804PubMed
35854717Clinical Data Cohort Quality Improvement: The Case of the Medication Data in The University of Minnesota's Clinical Data Repository.AMIA Jt Summits Transl Sci Proc2022https://conductscience.org/library/papers/35854717PubMed
35734519Real-World Insights Into Evolocumab Use in Patients With Hyperlipidemia: Canadian Analysis From the ZERBINI Study.CJC Open2022https://conductscience.org/library/papers/35734519PubMed
35635632LDL-C: The Only Causal Risk Factor for ASCVD. Why Is It Still Overlooked and Underestimated?Curr Atheroscler Rep2022https://conductscience.org/library/papers/35635632PubMed
35529057Low-Density Lipoprotein Cholesterol Levels in Coronary Artery Disease Patients: Opportunities for Improvement.Cardiol Res Pract2022https://conductscience.org/library/papers/35529057PubMed
35305172Statin use is associated with lower risk of dementia in stroke patients: a community-based cohort study with inverse probability weighted marginal structural model analysis.Eur J Epidemiol2022https://conductscience.org/library/papers/35305172PubMed

See all 60 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19954271

GET https://conductscience.org/api/papers/v1/19954271/cited_by?page=2